genprowebdirectory
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
  • Insights
    • Trends for 2020
    • Trends for 2021
    • Trends for 2023
  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
A password will be e-mailed to you.
Genetic Engineering & Biotechnology News GEN – Genetic Engineering and Biotechnology News
Genetic Engineering & Biotechnology News Genetic Engineering & Biotechnology News
  • GEN Edge
    • Featured News
    • Multimedia
    • Subscribe
    • Login
    • Contributors
  • News
    • Cancer

      Poor Lung Cancer Response to Immunotherapy Linked to Commensal Bacteria, Suppressed…

      Animal Models

      How Well Do Mouse Models Mimic Human Disease?

      GPCRs

      IPO Raises $161M for GPCR-Based Drug Developer Structure Therapeutics

      Immunology

      How Signaling Molecules of the Immune System Protect against Disease

      Lung Cancer
      Cancer

      Changing Carcinogenic Cells in the Lungs with Novel Technology

  • Insights
    • AllTrends for 2020Trends for 2021Trends for 2023
      Spatial Biology

      Spatial Biology Current State of the Art and What’s Coming Next

      Joseph M. Beechem
      Spatial Biology

      GEN Interview with Joseph M. Beechem, PhD, Chief Scientific Officer of…

      SMI Raw Data
      Spatial Biology

      Choosing the Right Spatial Technology

      CosMx SMI image
      Spatial Biology

      Spatial and NGS Dominate Proceedings at AGBT 2022

  • Topics
    • Artificial Intelligence
    • Bioprocessing
    • Cancer
    • Drug Discovery
    • Genome Editing
    • Infectious Diseases
    • OMICs
    • Translational Medicine
  • A-Lists
    • Hand Shake Meetings
      Drug Discovery

      Seven Biopharma Trends to Watch in 2023

      NIH Building
      A-Lists

      Top 50 NIH-Funded Institutions of 2022

      Bristol Myers Squibb building
      A-Lists

      Top 10 U.S. Biopharma Clusters

      Biomarker
      A-Lists

      Top 10 Spatial Biology Companies

      stocks go up
      A-Lists

      Top 25 Biotech Companies of 2022

  • Magazine
    • Current Issue
    • Past Issues
    • Supplements
    • Subscribe
  • Multimedia
    • Summits
    • Webinars
    • Learning Labs
    • GEN Live
    • Podcasts
  • Resources
    • eBooks/Perspectives
    • Tutorials
    • Biotech Briefs
    • Peer-Reviewed Journals
      • GEN Biotechnology
      • Re:Gen Open
    • New Products
    • Best of the Web
    • Best Apps
    • Conference Calendar
  • Subscribe
    • Get GEN Magazine
    • Get GEN eNewsletters
    • Get GEN Edge
Home Hematologic Conditions

Hematologic Conditions

  • 10x Genomics
  • A-Lists
  • AgBio
  • Age-Related Disorders
  • Aging
  • AGTC
  • alcohol
  • Alexandria Real Estate Equities
  • Allergic Diseases
  • Application Notes
  • Artificial Intelligence
  • Autoimmune Disorders
  • Bacterial Diseases
  • Bacteriophage
  • Base Editing
  • Bayer
  • Biodefense/Bioterrorism
  • Bioethics
  • Biomarker Discovery
  • BioNTech
  • BioPerspectives
  • Blockchain
  • Blood Disorders
  • Boehringer Ingelheim
  • Bone disorders
  • Brexit
  • Bristol-Myers Squibb
  • Cardiovascular Disease
  • Careers
  • Celgene
  • Cell Analysis
  • Cell Biology
  • Cell Culture
  • Cell Line Development
  • Cell Signaling
  • Cell Therapy
  • Cellular Analysis
  • China
  • Chromatography
  • Circadian Rhythm
  • Commentary
  • Compound Synthesis
  • Computational Biology
  • Computer Simulation
  • COVID-19 Candidates
  • CRISPR
  • CRISPR/Cas9
  • Danaher
  • Developmental Disorders
  • DNA Repair
  • Drug Resistance
  • Ear Disorders
  • Economic development
  • Education and training
  • Electrophoresis
  • Eli Lilly
  • Employment Trends
  • Endocrine Disorders
  • Evolution
  • Extracellular Matrix
  • Eye Disorders
  • Fill and Finish
  • Financing
  • Flow Cytometry
  • Forensics
  • Fungal Diseases
  • Gastrointestinal Disorders
  • GEN 40
  • GEN Edge
  • Genentech
  • Genetic Disease Testing
  • Genetics
  • Glycan Analysis
  • Glycoproteins
  • GWAS
  • Hematologic Conditions
  • Histology
  • HPLC
  • Hypertension
  • Imaging
  • Immunoassay
  • Immunochemistry
  • Immunology
  • In-vitro Fertilization
  • Industry News
  • Inflammatory Diseases
  • Information Management
  • Insights
  • interleukin
  • Ion Channels
  • Kidney Diseases
  • Kinases
  • Literature Review
  • Liver Diseases
  • Lung Cancer
  • Lung Diseases
  • Magazine
  • Marijuana
    Latest
    • Latest
    • Featured posts
    • Most popular
    • 7 days popular
    • By review score
    • Random
    Cancer

    Two by 2025: MorphoSys Consolidates Research, Retains Commercialization Goal

    Hematologic Conditions

    Response to Blood Platelet Disorder Therapy Predicted by Novel 3D Model

    cell survival protein
    Hematologic Conditions

    Potential Protein Protection for Kidneys from Cancer Therapies Discovered

    Hematologic Conditions

    Chimerix Licenses Cantex’s CX-01 for AML after Promising Phase II Results

    Hematologic Conditions

    After 2 Patient Deaths, FDA Imposes Partial Clinical Hold on Trial of Xencor Blood Cancer Antibody XmAb14045

    Hematologic Conditions

    AMAG Pharmaceuticals to Acquire Perosphere Pharmaceuticals

    Harbour BioMed will partner with Sichuan Kelun-Biotech Biopharmaceutical to develop and commercialize its Phase II cancer immunotherapy candidate A167 worldwide except greater China. The antibody is envisioned for use in a broad range of solid tumor and hematological malignancies
    Hematologic Conditions

    Harbour BioMed to Develop Kelun-Biotech’s Cancer Immunotherapy Candidate A167

    Recent research uncovers a new approach for expanding blood-forming
    Hematologic Conditions

    Reversible Technique Developed for Stem Cell Expansion

    Hematologic Conditions

    Curcumin Shown to Inhibit DYRK2 and Reduce Cancer Burden

    Synthetic biologists at the University of Bristol have succeeded in generating laboratory-made red blood cells with rare blood group types. [Dr. Ashley Toye/University of Bristol]
    Hematologic Conditions

    CRISPR Improves Red Blood Cell Transfusion Success

    Hematologic Conditions

    Model Wound System Created that Self Heals

    Hematologic Conditions

    Shire Hemophilia Candidate Using Xenetic Platform Falls Short in Trial

    Hematologic Conditions

    Nohla and UC Davis Ink Manufacturing Deal for Off-the-Shelf Donor Stem...

    Hematologic Conditions

    Novartis Acquires Selexys Pharmaceuticals

    Hematologic Conditions

    Takeda to Co-Develop Gencia’s MAGR Drugs in Up-to-$500M+ Partnership

    12Page 1 of 2

    Recently Featured

    Poor Lung Cancer Response to Immunotherapy Linked to Commensal Bacteria, Suppressed T-Cell Activation

    Poor Lung Cancer Response to Immunotherapy Linked to Commensal Bacteria, Suppressed T-Cell Activation

    How Well Do Mouse Models Mimic Human Disease?

    How Well Do Mouse Models Mimic Human Disease?

    How Signaling Molecules of the Immune System Protect against Disease

    How Signaling Molecules of the Immune System Protect against Disease

    Spatial Biology Current State of the Art and What’s Coming Next

    Spatial Biology Current State of the Art and What’s Coming Next

    Read the Digital Edition

    GEN February 2023 cover

    Explore

    • About GEN
    • Contact GEN
    • GEN Staff
    • Editorial Guidelines
    • Reprints and Permissions
    • Scientific Advisory Board

    Advertise

    • Media Kit and Planning Calendar
    • Magazine Advertising
    • Website Banner Advertising
    • eNewsletter Advertising
    • Webinar Sponsorship
    • eBook Advertising
    • List Rental
    • Advertising Terms and Conditions

    Resources

    • Get the GEN Magazine
    • Get the GEN Email Newsletter
    • Inside Precision Medicine
    • New Products
    • Videos
    • Webinars
    • Podcasts
    • Privacy Policy
    • Home
    • Terms of Service
    • Privacy Policy
    • Cookie Policy
    • Mary Ann Liebert, Inc.
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.
    sponsored
    Scroll Up